New method detects natural weight-loss peptides using artificial intelligence
While popular weight-loss drugs like Ozempic and Wegovy are widely used for their weight-reduction effectiveness, they often cause many side effects such as nausea, constipation, digestive disorders, and even muscle mass loss. The Stanford Medicine research team applied artificial intelligence (AI) to search for an alternative solution that could overcome these limitations.
Instead of developing a completely new drug, scientists used AI to search through thousands of natural proteins to find peptides with potential metabolic impact. The result was the discovery of a 12-amino acid BRP peptide that can reduce appetite sensations and body weight in animal test models.
Mechanism of action and differences from traditional GLP-1 drugs
GLP-1 drugs like semaglutide in Ozempic activate receptors in multiple organs such as the intestine and pancreas to regulate weight. For BRP, this peptide mainly affects the hypothalamus in the brain—the center controlling hunger sensations and energy metabolism. This focus may explain why animals receiving BRP do not experience the common gastrointestinal side effects typically seen with GLP-1 drugs.












